For a generic drug to be recognized as an adequate and appropriate substitution for a brand-name drug, the FDA formulated a simple equation 25 : Pharmaceutical Equivalence (PE) + Bioequivalence (BE) = Therapeutic Equivalence (TE) PE is demonstrated between two drug products if all of the following characteristics are identical 25 Dosage form Route(s) of administration Amount of active drug ingredient Amount of active drug ingredient delivered over a dosing period USP standard of drug identity, strength, quality, and purity BE is entirely determined by what happens to a drug after it enters the body
Side effects that remain intolerable despite adaptation time may indicate the need for dose reduction
Ipamorelins high-affinity selective GHS-R1a agonism makes it a research tool for studying ghrelin receptor biology in experimental contexts where selectivity for the GHS-R1a versus other ghrelin pathway receptors and downstream targets is required
Onoviran OF et al
OA is characterized by progressive loss of cartilage extracellular matrix (ECM) and pathological changes in other joint tissues such as subchondral bone sclerosis, osteophyte formation, and synovial inflammation 31
In Phase 3 clinical trials, participants started on 2mg once weekly